Oragenics, Inc.
OGEN
$0.183
$0.0084.57%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 73.73% | -22.36% | 24.44% | 13.85% | -469.67% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.47% | -13.06% | -8.49% | -13.38% | 11,393.10% |
| Change in Net Operating Assets | 50.01% | 29.86% | 76.02% | -205.88% | 853.73% |
| Cash from Operations | -83.07% | -31.09% | 40.06% | -45.31% | 54.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -29,311.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -45.43% | 0.08% | -17.52% | -16.33% | -14.88% |
| Issuance of Common Stock | 1,900.00% | 356.97% | -- | -- | -99.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.46% | 414.37% | 861.08% | 1,134.23% | -105.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.17% | 353.87% | 73.05% | 37.78% | 9.56% |